Live Event

Internal Medicine: Hospital Medicine/Rheumatology/Medical Marijuana – A Practical Approach

Title:Internal Medicine: Hospital Medicine/Rheumatology/Medical Marijuana – A Practical Approach
Dates:July 13, 2020 8:00 am - July 17, 2020 12:15 pm
Location:Crowne Plaza, Orlando, Florida
Daily Schedule:8:00 am-12:15 pm
Course #:SEMLA-3420200713

Certifications

20 AMA PRA Category 1 Credits™

PLEASE CLICK HERE TO BOOK YOUR HOTEL ROOM FOR THIS CONFERENCE


Venue

304 West Colonial Drive
Crowne Plaza, Orlando
Florida
32801
United States

If you’re looking for a great location near everything Central Florida has to offer, look no further than the Crowne Plaza Orlando Downtown. Seeing Cinderella’s Castle, Play in the Parks with Mickey and his Friends, Hogwarts School of Witchcraft and Wizardry at the Wizarding World of Harry Potter, or visit the world famous Church St Station in Downtown Orlando. See the Orlando Magic rule the NBA, attend a performance at the Dr. Phillips Center for the Performing Arts, or catch a concert at the Amway Center, all just a few blocks from the hotel.

  • Parking rate reduced to $5 for self-parking or $15 for valet parking per day
  • Complimentary Wi-Fi
  • Complimentary Shuttle-Service with-in a 3 mile radius 7am – 10:30pm
  • No Resort or Maid Fees
  • 24-Hour Access to Business Center
  • 24-Hour Access to Fitness Center

 

Rent a Car with Enterprise or National:
To book your CME conference car rental and to receive special rates exclusively for AMS attendees, you may call or book online with our contracted companies, Enterprise Rent-A-Car or National. To receive exclusive rates, use the code listed below.

Group Discount Code – Corp #XZ35AMS


Course Outline

Day 1

Approach to the Patient with Rheumatic Diseases.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Demonstrate the importance of the history and physical exam including patterns of joints involvement and extra-articular findings in evaluating patients with rheumatic diseases.
  2. Distinguish inflammatory (i.e. rheumatoid arthritis) and structural arthritis (i.e. osteoarthritis).
  3. Differentiate patterns of articular involvement associated with different arthritides.
  4. Utilize laboratory and radiological studies in the evaluation of patients with rheumatic diseases.

Lyme Disease and Other Topics in Rheumatology.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Apply CDC and Infectious Diseases Society of America Guidelines for the diagnosis, treatment, and prevention of Lyme disease.
  2. Evaluate skin rashes as manifestations of systemic diseases.
  3. Using the Guidelines of the Bone Research Society of the United Kingdom to prescribe appropriate therapy for patients with Paget’s disease of the bone.

The History of Medical Marijuana.

Upon completion of this session, the participant should be able to:  COMP

  1. Describe the origins and botany of the marijuana plant.
  2. Articulate the beginnings of human consumption of Cannabis derivatives for medicinal purposes.
  3. Evaluate the history of criminalization of marijuana in the U.S.A.
  4. Discuss the history of worldwide acceptance of medical applications of Cannabis
  5. Review some of the current legislation in the US as it pertains to Medical Marijuana.

The Science Behind Cannabis Pharmacology.

Upon completion of this session, the participant should be able to: COMP

  1. Understand the central mechanism of action for the most common cannabinoids.
  2. Define and understand the role of the Endocannabinoid system.
  3. Describe the pharmacological effects on the human body through a system-based approach.
  4. Discuss toxicity levels of THC and impact on overall health.
  5. Understand the mechanism behind tolerance and dependence.

Day 2

Systolic and Diastolic Heart Failure.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Appropriately manage decompensated heart failure in hospitalized patients.
  2. Assess the indications for positive inotropic agents and ultrafiltration in systolic heart failure.
  3. Distinguish the treatment of systolic versus diastolic heart failure, as per the 2013 ACCF/AHA Guidelines for heart failure management.

Atrial Fibrillation in the Hospitalized Patient.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Assess and evaluate treatment options for atrial fibrillation with rapid ventricular response, as per the 2010 HFSA Guidelines.
  2. Employ appropriate anticoagulation strategies for atrial fibrillation.
  3. Distinguish the advantages of rhythm versus rate control treatment strategies, 2014 ACC/AHA Guidelines for atrial fibrillation management.
  4. Determine the possible underlying causes of CHF exacerbations.

Conditions that May Benefit from Medical Marijuana and Future Studies.

Upon completion of this session, the participant should be able to: COMP, EBM

  1. Identify qualifying conditions in specific medical specialties that may benefit from Medical Marijuana therapy.
  2. Describe traits of conditions that have qualified for government approval.
  3. Contrast clinical risks of medical marijuana use.
  4. Critically evaluate evidence-based research findings for specific qualifying conditions.
  5. Define roadblocks and controversy to cannabis research.

Prescribing Medical Marijuana (Dosing, Strains and Delivery Systems).

Upon completion of this session, the participant should be able to: COMP

  1. Review and solidify understanding of cannabis pharmacology.
  2. Differentiate between strains and routes of delivery for medical marijuana therapy.
  3. Understand and recommend dosing regiments for medical marijuana.
  4. Discuss dosing for short-term and long-term health benefits of medical marijuana.
  5. Discuss the controversies and side-effects of medical marijuana use.

Day 3

Crystal Arthritis.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Demonstrate the clinical presentations and manifestations in the course of gout.
  2. Monitor and prescribe treatment for patients with gout according to the EULAR and ACR recommendations and guidelines.
  3. Demonstrate the clinical presentations, manifestations, and treatment of calcium pyrophosphate deposition disease (CPPD) and pseudogout.

Rheumatoid Arthritis.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
  2. Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
  3. Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
  4. Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines. 

Challenging Infections: MRSA and C. difficile.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Assess and apply appropriate treatment strategies for different types of methicillin resistant staph aureus infections.
  2. Employ rational use and relate the precautions of newer antibiotics when treating resistant bacteria.
  3. Distinguish Guideline based treatment of Clostridium difficile

Novel Oral Anticoagulants.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Differentiate the advantages and disadvantages of commonly used anticoagulants.
  2. Employ evidence-based anticoagulation bridging regimens.
  3. Assess the approved indications for various anticoagulation agents.
  4. Apply the evidence-based indications for anticoagulation in hospitalized patients.

Day 4

Update in Perioperative Medicine.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Appraise pre-operative cardiac risk stratification and management strategies, as per the ACC/AHA Risk Clinical Predictors.
  2. Determine the role of non-invasive stress testing, echocardiography, coronary angiography and the use of biomarkers to assess peri-operative cardiac risk, as per the ACC/AHA (2014) Perioperative CV Evaluation Guidelines.
  3. Relate the indications for beta blockers, statins and aspirin in the peri-operative period.
  4. Evaluate the bleeding risks of commonly prescribed medications and OTC supplements taken pre-operatively.

Consultative Medicine: Transfusion Guidelines, Delirium in the Hospitalized Patient.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Interpret changes in the updated 2012 American College of Chest Physicians Evidence-Based Guidelines for Antithrombotic Therapy.
  2. Assess restrictive red blood cell transfusion strategy as recommended by American Association of Blood Banks (AABB) guidelines.
  3. Evaluate clinical factors that make patients more prone to hospital and postoperative delirium.
  4. Employ evidence-based strategies to treat delirium in hospitalized patients. 

Spondyloarthropathies.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
  2. Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
  3. Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.

Septic Arthritis.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Determine the risk factors associated with septic arthritis.
  2. Utilize the British Society of Rheumatology Guidelines for management of the hot swollen joint in adults to differentiate septic arthritis from other causes of acute monoarticular arthritis.
  3. Utilize epidemiological and clinical clues to determine bacterial etiology in patients with septic arthritis.

Day 5

Scleroderma and Raynaud’s Disease.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Specify the clinical manifestations of scleroderma.
  2. Apply the ACR/EULAR classification criteria for systemic sclerosis.
  3. Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
  4. Apply the diagnostic work-up and treatment of Raynaud’s phenomenon.

Systemic Lupus Erythematosus.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Describe the varied clinical presentations and manifestations in the course of systemic lupus erythematosus.
  2. Order and interpret laboratory testing used in the diagnosis of systemic lupus erythematosus in accordance with ACR Guidelines.
  3. Monitor and employ treatment options for patients with systemic lupus erythematosus according to EULAR recommendations and evidence-based results from clinical studies. 

Intro to Palliative care.

Upon completion of this session, the participant should be able to: COMP

  1. Identify pain and symptom management, which enhances quality of life, as a primary focus of palliative care
  2. Analyze best practices for discussions on disease prognosis, goals of care, suffering, advance care planning, and code status.
  3. Evaluate the treatment of anxiety, shortness of breath, insomnia, and constipation in patients with multiple serious chronic medical conditions.

Common Cases Walking Through Your Office Door.

Clinical Cases will be solicited throughout the week from the participants.  These cases will be selected and managed by the presenters. Diagnoses, next steps in management and expected clinical outcomes will be discussed.  The format will include panel discussion and audience participation.

Presented By

Presenter

  • Lawrence H. Brent, M.D. (Learn More)
    Professor of Medicine, Division of Rheumatology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  • Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M. (Learn More)
    Chief Hospitalist, St. Joseph Hospital and Medical Center, Phoenix, AZ; Clinical Assistant Professor Creighton University School of Medicine; Clinical Assistant Professor, University of Arizona College of Medicine
  • Benjamin M. Kaplan, M.D., M.P.H., F.A.C.P. (Learn More)
    Orlando Health Internal Medicine Faculty Practice; Internal Medicine Clerkship Director and Clinical Assistant Professor; Florida State University College of Medicine

Fee Structure

To receive the Early Registration Rate, fees must be postmarked >60 days prior to program start date (July 13, 2020 8:00 am).

Register

Details Price Qty
Physician’s Fees – Early Registration $849.00 (USD)  
Physician’s Fees – Regular Registration $899.00 (USD)   Goes On Sale
May 12, 2020
Non Physician/Resident Fees - Early Registration $749.00 (USD)  
Non Physician/Resident Fees - Early Registration $799.00 (USD)   Goes On Sale
May 12, 2020

Need help? Have a question?

mail@ams4cme.com 1-866-267-4263 Disclaimer: AMS reserves the right to cancel any conference within 6 weeks of conference date. Registrants will receive a full refund within 7 business days. AMS is not responsible for charges associated with canceled flight or hotel rooms. AMS Cancellation Policy: Although it is rarely necessary, American Medical Seminars, Inc. reserves the right to modify speakers and subject matter. American Medical Seminars, Inc. assumes no liability beyond the refund of the seminar registration fee. In the unlikely event that AMS postpones or cancels this conference due to circumstances beyond our control, you will be provided with a refund for the registration fee or you can opt to transfer to another of our live events.